Volume 89, Issue 3, Pages 666-674 (March 2016) Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients  Emilie Merle, Hubert Roth, Gérard M. London, Guillaume Jean, Thierry Hannedouche, Jean-Louis Bouchet, Tilman Drüeke, Denis Fouque, Eric Daugas  Kidney International  Volume 89, Issue 3, Pages 666-674 (March 2016) DOI: 10.1016/j.kint.2015.12.001 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Flow chart of patient enrollment and outcome from month 0 (October 2010) to month 24 (October 2012). iPTH, intact parathyroid hormone. Kidney International 2016 89, 666-674DOI: (10.1016/j.kint.2015.12.001) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Treatment dosage distribution of the 1983 incident patients undergoing hemodialysis at month 6, with intact PTH values at month 0 and month 12 included in the study. ∗Prescription of “nonactive” vitamin D was recorded in 1335 of the 1983 incident patients undergoing hemodialysis. Among them, 1020 patients (76.4%) received cholecalciferol, 308 patients (23.1%) received 25-OH vitamin D, and only 7 patients (0.5%) received ergocalciferol. †Active vitamin D was recorded in 352 of the 1983 patients. Only 19 patients (1% of the 1983 patients) were prescribed an i.v. vitamin D analogue. Kidney International 2016 89, 666-674DOI: (10.1016/j.kint.2015.12.001) Copyright © 2016 The Authors Terms and Conditions